{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-013314","form_type":"8-K","ticker":"ENSC","cik":"0001716947","company_name":"Ensysce Biosciences, Inc.","filed_at":"2026-03-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.988477+00:00","generated_at":"2026-05-15T08:24:19.269498+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"confidence":"high","headline":"Director Lee Rauch resigns from Ensysce board over severance package dispute","bullets":["Lee Rauch resigned effective March 24, 2026, citing disagreement with board-approved severance packages.","Packages provide up to $205,475 in potential severance for CFO and three managers during strategic review.","CFO retention package increased from 6 to 9 months; packages contingent on non-retention in any strategic deal.","Board approved packages on March 27, 2026; Rauch had previously expressed other disagreements.","Company continues evaluating strategic alternatives for its business."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-013314","json":"https://secwatch.observer/filing/0001493152-26-013314.json","markdown":"https://secwatch.observer/filing/0001493152-26-013314.md","text":"https://secwatch.observer/filing/0001493152-26-013314.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716947/000149315226013314/0001493152-26-013314-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716947/000149315226013314/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:24:19.269498+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}